Show simple item record

dc.contributor.authorPerez-Caballero, Laura
dc.contributor.authorPérez, V.
dc.contributor.authorBerrocoso Domínguez, Esther María 
dc.contributor.otherNeurocienciases_ES
dc.contributor.otherPsicologíaes_ES
dc.date.accessioned2025-07-11T09:11:22Z
dc.date.available2025-07-11T09:11:22Z
dc.date.issued2020
dc.identifier.issn1746-045X
dc.identifier.issn1746-0441
dc.identifier.urihttp://hdl.handle.net/10498/36694
dc.formatapplication/pdfes_ES
dc.language.isoenges_ES
dc.publisherTaylor and Francises_ES
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.sourceExpert Opinion on Drug Discoveryes_ES
dc.titleWhat ketamine can teach us about the opioid system in depression?es_ES
dc.typeeditoriales_ES
dc.rights.accessRightsopen accesses_ES
dc.identifier.doi10.1080/17460441.2020.1781812
dc.type.hasVersionVoRes_ES


Files in this item

This item appears in the following Collection(s)

Show simple item record

Attribution-NonCommercial-NoDerivatives 4.0 Internacional
This work is under a Creative Commons License Attribution-NonCommercial-NoDerivatives 4.0 Internacional